Validation,
engineered for
biopharma.
PMBS delivers next-generation commissioning, qualification and validation services for greenfield and brownfield biopharmaceutical manufacturing facilities — operating at the intersection of pharmaceutical engineering and validation science.
Six capabilities.
One accountable partner.
C&Q
Commissioning & Qualification. Commissioning & Qualification plans, IQ/OQ/PQ, traceability matrices, V-model execution.
CSV
Computer System Validation per GAMP 5 & EU Annex 11, 21 CFR Part 11. Risk-based and data-integrity first.
Engineering
URS, P&IDs, mass balance, scale-up and tech-transfer for USP, DSP and Fill/Finish unit operations.
Process Automation
DCS · PLC · SCADA · MES. Control philosophy, FAT/SAT and integrated commissioning.
Design Engineering
Conceptual & basic design for greenfield and brownfield biopharma facilities, with HVAC and utility integration.
Audit Readiness
GMP gap assessments, remediation plans and mock inspections for FDA, EMA, MHRA, CDSCO and PIC/S.
Built for the
modalities of tomorrow.
Biologics & mAbs
CHO, microbial, recombinant proteins, monoclonal antibodies.
Vaccines
Viral vector, mRNA and conjugate vaccine facilities.
Cell & Gene Therapy
Autologous and allogeneic platforms, viral vector production.
Biosimilars
Comparability-driven C&Q for biosimilar manufacturing.
Sterile Fill / Finish
Isolators, RABS, lyophilizers and visual inspection lines.
API & Small Molecule
Solid dosage, OSD, parenterals and clinical manufacturing.
Not on the list? Talk to us. PMBS regularly supports utility, packaging and QC lab qualification programs.
Start a conversation →We commission the facilities that make tomorrow's medicines — and we hold them to the standards regulators apply today.
Pristinemed Bioprocess Solutions is a specialist engineering and validation partner for biopharmaceutical manufacturers. We bring deep expertise in C&Q, CSV, GMP compliance, DCS automation, design engineering and engineering to greenfield and brownfield facilities.
Our practice is founder-led and engineer-staffed — we put the lead names you signed onto the project floor, not just on the proposal. Every engagement is scoped against the regulatory framework your product will face, from IND through commercial launch.
Five phases.
One audit-ready outcome.
Fluent in the frameworks
that govern your release.
- ·US FDA 21 CFR Part 11
- ·21 CFR Part 210/211
- ·cGMP Q7
- ·EU GMP Annex 11
- ·EU GMP Annex 15
- ·EMA Guidelines
- ·ICH Q7 · GMP for APIs
- ·ICH Q9 · Quality Risk Mgmt
- ·ICH Q10 · Pharma Quality
- ·ISPE GAMP 5
- ·ISPE Baseline Guides
- ·ASTM E2500
- ·WHO TRS
- ·PIC/S PI 041
- ·PE 009
- ·CDSCO Schedule M
- ·MHRA
- ·PMDA · KFDA